ArticleJMIR public health and surveillance2026
Postpandemic Change in Demographic and Clinical Features of Patients With Omicron Who Were Hospitalized: Territory-Wide Retrospective Repeated Cross-Sectional Study in Hong Kong.
Article in JMIR public health and surveillance, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A randomized controlled trial protocol of herbal formulas for modifying susceptible body constitution to enhance COVID-19 resistance in Hong Kong residents.Journal of thoracic disease · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The Omicron variant of SARS-CoV-2 underwent several mutations since it was first identified in November 2021, with a large outbreak in Hong Kong in early 2022. Yet, local cases of Omicron infections persist, even though the COVID-19 pandemic ended in May 2023. Objective: This study aims to describe the changes in demographic and clinical characteristics of patients infected with COVID-19 across different Omicron waves in Hong Kong and determine whether the changes continued into the postpandemic period. Methods: This retrospective repeated cross-sectional study collected data on patients infected with COVID-19 admitted to public hospitals in Hong Kong between May 1, 2022, and May 31, 2024. These data were later categorized into 3 periods based on the Omicron strain. A subsequent age-stratified descriptive analysis was conducted on each characteristic to identify any significant differences across the periods. Results: First, the case fatality ratio significantly lowered among those older than 85 years (1.5% proportion decrease, period 1: 11.6%, period 2: 10.1%, effect size: 0.02; P<.001). Second, most patients were Chinese (≥68.7% per age group and period), and females were predominantly infected for those aged older than 85 years (≥56.9% per period). Third, the Charlson Comorbidity Index scores in most age groups showed a predominant proportion of infected individuals with 0 scores (more than 70% per period). Fourth, most cases were from slightly disadvantaged populations in Hong Kong (≥30.5% per age group per period). Fifth, clinical management of Omicron hospitalizations showed lowered length of hospital stays among adults and older individuals (≥1 d decrease between periods 1 and 3, per age group), as well as increased administration of bronchodilators. Conclusions: Despite the decreasing incidence of Omicron cases admitted to public hospitals in Hong Kong, the increasing case fatality ratio with age suggests that long-term surveillance of COVID-19 should be maintained to prepare for potential mutations and outbreaks.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.